| Trial ID: | L2062 |
| Source ID: | NCT02118376
|
| Associated Drug: |
Exenatide
|
| Title: |
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Obesity
|
| Interventions: |
DRUG: Exenatide
|
| Outcome Measures: |
Primary: Dual energy X-ray absorptiometry, fat distribution, 3 month | Secondary: lab testing, inflammation, 3 month | Other: lab testing, liver function, 3 months
|
| Sponsor/Collaborators: |
Sponsor: Shanghai 10th People's Hospital
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-08
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2014-04-21
|
| Locations: |
Shanghai Tenth People' Hospital, Shanghai, Shanghai, 200072, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02118376
|
